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MONEYBALL IN THE ERA OF BIOMETRICS: WHO
HAS OWNERSHIP OVER THE BIOMETRIC DATA OF
PROFESSIONAL ATHLETES?
Christopher Casher*
ABSTRACT
The 2003 release of Michael Lewis’s book, Moneyball, brought into the
mainstream a new paradigm for professional sports management: the
use of statistical analysis to identify currently undervalued athletes in
an effort to gain a competitive advantage. This pressure to accurately
value athletes has led, in part, to the widespread collection of
professional athletes’ biometric data. While biometric data can create
many benefits, its misuse can lead to detrimental outcomes for the
athletes, including inequitable contract negotiations, loss of potential
revenue from monetization of said data, and a loss of privacy. Thus,
this paper seeks to determine who holds the ownership rights over
biometric data collected from professional athletes. I argue that the
question of ownership is unanswered by the collective bargaining
agreements and standard player contracts for professional sports
leagues in North America, as well as by the Personal Health Information
Protection Act and the Personal Information Protection and Electronic
Documents Act. I turn to the precedent set by the Supreme Court of
Canada regarding ownership of patient medical records to conclude
that ownership rights over the biometric data belong to the party
collecting such data, and not the athletes themselves. Nevertheless, the
collective bargaining agreements and relevant legislation afford
athletes some protections against the misuse of their biometric data.
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INTRODUCTION
In many ways, the discussions surrounding professional sports in North
America would be almost unrecognizable to the average fan 20 years ago. Each
Sunday, cameras capture quarterbacks and coaches staring at tablet computers on
the sidelines, studying previous drives. The debate over the National Basketball
Association’s (NBA) Most Valuable Player Award has fans comparing newly
popularized statistics such as player efficiency rating, true shooting percentage,
and points per possession.1 Major League Baseball (MLB) teams advertise
openings for sabermetrics analysts in their front offices.2 Each development
represents an evolution to the paradigms that have traditionally governed sports
management. Among these evolutions is the collection and analysis of biometric
data.
The adoption of new technologies has resulted in major changes within
professional sports. As so often happens, this development in technology has
occurred faster than the law can adapt, creating questions around use and
regulation. Among these, who holds the ownership rights to the biometric data
of professional athletes gathered from wearable devices in games and in practice?
What regulations, if any, currently exist for the collection, use, and disclosure of
this data? I seek to answer these questions in this paper. I will begin by exploring
the context in which the development of biometric tracking in sports arose,
considering the current rise of the use of analytics in professional sports. Next, I
will define the term biometric data, examine how it is being utilized in
professional sports, and identify the harms that may arise from its unregulated
use. I will then explore the implications of contract law, labour law, applicable
legislation, case law and explore any existing regulations to answer the question
of ownership over biometric data.
To aid in this analysis, I will employ certain parameters and presumptions.
To begin, the research for this paper has been conducted from the perspective of
Basketball Reference, “Calculating Individual Offensive and Defensive Ratings” (last visited 9 April 2018),
online: Basketball Reference < https://www.basketball-reference.com/about/ratings.html>.
2 Ben Lindbergh & Rob Arthur, “Statheads Are The Best Free Agent Bargains In Baseball”, FiveThirtyEight
(26 April 2016), online: <https://fivethirtyeight.com/features/statheads-are-the-best-free-agent-bargains-inbaseball/>.
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a professional athlete who is a resident of Ontario, playing for a private sports
organization located in Ontario. Thus, relevant provincial and federal legislation
has been considered. Further, this athlete is presumed to have signed the relevant
standard form contract provided for within the respective collective bargaining
agreements (CBAs). The fact that four of the five major professional sports
leagues are located in the United States raises jurisdictional questions as to the
application of Canadian law over certain athletes. Conclusions to these questions
are inherently factually specific, and thus beyond the scope of this paper, which
attempts to conduct an environmental scan of this issue rather than suggest
practical application. However, I have attempted to address these questions
where relevant. Further, it is possible that the question of data ownership can be
addressed through private contract clauses either between the team and the
athlete, or between the team and the company providing biometric tracking
technology. Given this limitation, I instead seek to consider the legal influences
beyond a clause in a private player contract that will either supplement situations
where a contract is silent on the issue of biometric data ownership, or, potentially
supersede one that is not.
From the perspective of this hypothetical professional athlete, I will analyze
the three major sources of legal influence over the relationship between the
athlete and their team to determine the question of ownership rights. First, I will
explore the CBAs entered into between the players’ unions and the respective
North American sports leagues to determine whether the question of ownership
has already been negotiated. Next, I will analyze applicable provincial and federal
legislation to determine if the legislature has addressed this question. Finally, I
will delve into the relevant and analogous case law to determine if the courts have
addressed the question of ownership. Based on this analysis, I conclude that the
precedent set by the Supreme Court of Canada regarding ownership of patient
medical records suggests that the biometric data collected from professional
athletes belongs to the party that collected such data, and not the athletes
themselves.
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THE RISE OF SPORTS ANALYTICS
Professional sports teams operate in a marketplace, with regulations
intended to both level the playing field and to increase competitiveness within the
league. A salary cap limiting what teams can spend on athlete salaries exists to
address the resource imbalance between large and small market teams. The athlete
drafting process, which is designed to put the worst performing teams in the best
position to sign the most talented incoming athletes, helps address talent
imbalances. Further, teams have to be selective with the athletes they sign, as
CBAs impose limitations on the number of active athletes each team can have.
Thus, teams are under great pressure to properly evaluate each athlete’s abilities,
so as to maximize the success of the team while minimizing costs. To meet this
pressure, teams utilize analytics (the analysis of athlete performance data) to
influence athlete management decisions.3
As long as professional teams have competed for championships,
management has utilized some form of analytics to evaluate athletes. 4 What has
changed over time are the metrics used to evaluate athletes, the technology used
to obtain these metrics, and how these metrics are interpreted.
The practice of using statistical analysis to influence management decisions
was relatively marginal until the 2003 release of Michael Lewis’s best seller,
Moneyball, after which the practice was popularized and began to become
legitimized by league executives across MLB.5 The release of this book was such
a watershed moment that its title, Moneyball, is still used today to refer to the
application of statistical methods on athlete performance, regardless of the sport
in question.6 The logic behind Moneyball is quite simple; through statistical
Benjamin Baumer & Andrew Zimbalist, The Sabermetric Revolution: Assessing the Growth of Analytics in Baseball
(Philadelphia: University of Pennsylvania Press, 2014) at 11, 30.
4 The demand for the analytical evaluation of incoming athletes is well demonstrated through the National
Football League’s (NFL) scouting “combine”, wherein college football athletes who have declared for the
draft are evaluated on certain drills which teams believe to be indicative of an athlete’s potential. This event
began in the 1980’s, when teams lacked the resources needed to properly evaluate athletes from across the
country. Even though this resource gap has largely been eliminated, the persistence of the scouting
“combine” indicates the NFL’s demand for analytics. For more on this topic, see Kevin Clark, “The NFL
Combine Has a Usefulness Problem” (26 February 2016), online: The Wall Street Journal
<https://www.wsj.com/articles/the-nfl-combine-has-a-usefulness-problem-1456533621>.
5 Baumer, supra note 3 at 1, 12, and 90.
6 Ibid at 11, 17, and 27.
3
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analysis, management can identify undervalued athletes to gain a competitive
advantage. While Lewis was successful in telling the story of the 2002 Oakland
Athletics, his success also began to erode the competitive advantage upon which
the team’s success was based.7 This has led to a continuous search for new metrics
by which teams can identify undervalued athletes. As discussed in greater detail
below, it is this pressure for a new competitive advantage which has, in part, not
only led to teams collecting biometric data, but has also created the incentive to
misuse this data to the athletes’ detriment.

BIOMETRIC DATA
Defining the Term

Instead of tracking an athlete’s in-game performance, biometric data
measures the performance of an athlete’s body during the game. The term
“biometric data” has a broad definition, referring to the measurement and
tracking of physical and physiological characteristics. This information has many
potential uses, but in relation to sports and athletics it is mainly used to assess the
performance and recovery of athletes.8 The physical and physiological
characteristics measured varies depending on the specific technology used, and
the purpose it is being used for, however, these measurement possibilities will
only increase as the technology continues to develop. While mainstream
biometric trackers today are limited to measurements from sensors placed on the
skin, industry insiders predict that more invasive sensors, either ingested or
implanted, with the ability to measure a greater amount of data are not far off the
horizon.9 Given that the use of this technology will only increase, it is important
to consider basic legal questions early in its development.
Currently, biometric trackers function by placing wireless sensors on
athletes’ bodies, which in turn relay the data collected in real time to hand-held
computers and tablets. These devices then use proprietary software to interpret
Ibid at 37.
Katrina Karkazis & Jennifer R Fishman, “Tracking US Professional Athletes: The Ethics of Biometric
Technologies” (2017) 17:1 American J Bioethics 45 at 45-46.
9 Ibid at 47.
7
8
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the data based upon the team’s needs.10 We can look to the services advertised by
one of the industry leaders, STATSports to illustrate to potential of biometric
data collection. While the services advertised are not necessarily indicative of the
true capabilities of the product, a brief summary demonstrates what services are
available in the market.
On its website, STATSports tailors its advertisements to its product’s
usefulness in individual sports. Under American football, it advertises that its
wearable devices track over 50 metrics. These metrics vary from the athlete’s
running speed and distance to more advanced metrics such as the reaction time
and acceleration after the snap and the impact received. Through the collection
of enough data, STATSports advertises that its product will learn each athlete’s
individual level of conditioning and understand how close each athlete is to full
exertion. It also advertises that its product can assist by detecting how much an
athlete has recovered from injuries by using metrics such as “left vs right foot
impacts …[which] can give coaches and athletic trainers data showing whether a
rehabilitating athlete is putting more force through his healthy side and therefore
going easy on the injured leg. Coaches can see whether or not a athlete is fully
ready to return.”11 Other metrics advertised for basketball include heart rate
exertion, acceleration, explosive distance and a fatigue index.12 These advertised
metrics demonstrate how these companies take the basic physiological
measurements, and use software to interpret the data in a method tailored to the
needs of the targeted sport.
Use and Potential Misuse in Professional Sports

Ostensibly, teams use biometric monitoring devices to both assist athletes
in avoiding injury (by preventing overexertion) and to monitor injury recovery.13
By tracking athletes’ biometric statistics in real-time, teams can better understand
how athletes are recovering from their games, practices, and workouts, identify
Ibid at 45.
STATSports, “Football”, online: <http://statsports.com/football/>.
12 STATSports, “Basketball”, online: <http://statsports.com/basketball/>.
13 Natalie Weiner, “Goal Line Lasers, Football Sensors and More: Why the NFL Is Slow to New Tech”,
Bleacher Report (29 January 2018), online: <http://bleacherreport.com/articles/2756568-goal-line-lasersfootball-sensors-and-more-why-the-nfl-is-slow-to-new-tech>.
10
11
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which athletes are at risk of injuring themselves, and adjust the athlete’s
environment accordingly.14
This understanding of the way teams use biometric data, however, is naïve
to say the least. There are too many incentives and too much opportunity for this
data to be used to benefit the parties in power at the athletes’ expense. Two of
the main harms that can arise from the misuse of biometric data are inequitable
outcomes in contract negotiations, and an athlete’s loss of privacy rights.
Given the substantial salary the average professional athlete now earns, it
may be difficult to comprehend how their contract negotiations can be
considered inequitable. For clarity, I am not suggesting that these harms reach
the level of unjust enrichment, or that they would make the execution of these
contracts unconscionable. Certainly, the presence of agents on behalf of the
athletes and the processes outlined in the CBAs would severely inhibit these
arguments. Instead, I argue that asymmetric access to the athlete’s biometric data
can result in inequitable outcomes for future contracts. 15
Athletes represent significant investments for a team, financially and in
terms of the opportunity-cost the athlete’s spot on the roster takes.16 A team is
therefore incentivised to have as much data as possible on its athletes, which
includes biometric data. Inequity can arise, however, when the use of the data is
masked, or if the data itself is inaccurate. With the ever-increasing amount of
data available to team managers, it is almost inevitable for this data to influence
contract negotiations.17 This influence can become inequitable to the athlete if he
or she is unaware of the data’s influence, resulting in teams negotiating lower
contracts on the basis of information that the athlete may not have access to.
Masking the data is not difficult to do. If there is an athlete who is often out too
late and whose sleep trackers indicate a lack of sleep, management might refer to
them as having bad character. An athlete who does not have a high enough heart
rate during certain drills in practice can be painted as lacking effort. If an athlete
has low oxygen intake during sprints, the team may write them off as having low
Jeremy Venook, “The Upcoming Privacy Battle Over Wearables in the NBA”, The Atlantic (10 April 2017),
online: <https://www.theatlantic.com/business/archive/2017/04/biometric-tracking-sports/522222/>.
15 Black’s Law Dictionary, 10th ed, sub verbo “inequity.”
16 Venook, supra note 14.
17 Ibid.
14
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endurance.18 Whether or not the biometric data is a fair representation of athletic
qualities, not informing the athlete of the data underlying these qualifications can
put them at a disadvantage.
The above problem assumes that the devices collecting the data are accurate
and are being used for their proper purpose. However, many of these devices use
various algorithms to simplify the complex factors recorded. As Karkazis and
Fishman note in their article on the subject, “[when] thinking about the utility of
an algorithm, it is not simply a question of whether it is the right algorithm for
the job, but whether a concept like athlete recovery can ever be captured by an
algorithm.”19 Further, there is the risk that those interpreting the data may not
understand what the data represents. Team management can conflate the process
with the result, separating the data from the performance it is intended to beget.20
Another example showing how biometric data can be used to harm an
athlete’s interest is found in the terms of the standard player contracts in the
CBAs of each league. Each contract contains a clause that is substantially similar
to this one, taken from the National Hockey League (NHL) player contract,
wherein the player covenants “to keep himself in good physical condition at all
times during the season,” with the potential for the athlete’s contract to be
terminated if this representation is not upheld.21 Previously, these clauses were
interpreted subjectively. Now, biometric data captured from athletes can make
the interpretation of these clauses more objective in determining what is to be
considered “good physical condition,” without the athlete necessarily knowing
what the objective standard is that they are required to meet, or how the data will
be used in this interpretation.22
Another set of potential harms from the use of biometric data is the
potential for breaches of the athlete’s privacy interests. As one legal commentator
noted, “unlike previous advances in analytics, biometric data provides
Ibid.
Karzakis, supra note 8 at 49.
20 Venook, supra note 14.
21 “Collective Bargaining Agreement between NHL and NHLPA, September 16, 2012 – September 15,
2022”, online (pdf): NHLPA <https://www.nhlpa.com/the-pa/cba> at Exhibit 1, s 2(b) [NHL-NHLPA
Agreement].
22 Karzakis, supra note 8 at 50.
18
19
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information about the basic mechanics of a player’s body that is [not] available to
the naked eye, or even the high-tech-camera-enhanced eye.”23 This data has
inherent privacy interests associated with it, and thus issues of disclosure are
especially concerning. Athletes have an inherent interest in determining who has
the ability to access their biometric data, an interest that is more difficult to
protect without ownership rights over the data. Further, even with strong storage
and disclosure procedures in place, there is a real risk that this data can still be
leaked to the public.24 Various groups, such as fans and fantasy sports
participants, looking to get a competitive advantage and who have obvious
interests in obtaining the data, increase this risk. The potential market for this
information, coupled with the innate privacy interests associated with the data,
have led many to argue that if this biometric data can be monetized, it should be
the athletes, and not the teams, who benefit from this monetization.25

COLLECTIVE BARGAINING AGREEMENTS
In each of the major North American sports leagues, the relationship
between the athletes and their teams are governed by CBAs negotiated between
the various athletes’ unions and their respective leagues. Players unions have
strongly advocated with the leagues to negotiate CBAs that respect and protect
the interests of the athletes. It is likely that the collection and use of biometric
data will be included in the CBAs, given the potential harms identified with the
practice. If the CBA directly addresses the issue of biometric data ownership, or
if the assignment of the data’s ownership can be reasonably read into an existing
clause, then the ownership rights will clearly be determined.
As previously noted, I am conducting this review through the lens of
Ontario law, contrary to the choice of law clauses present in many of the CBAs.
Addressing this potential conflict of laws, while beyond the scope of this paper,
is also not necessary to determine the question I seek to answer. A simple textual
interpretation of the CBAs reveals that ownership rights over biometric data have
Venook, supra note 14.
Ibid.
25 Karzakis, supra note 8 at 57.
23
24
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not been explicitly negotiated for in any CBA or standard player contract and
helps develop our understanding of the legal landscape surrounding biometric
data collection.
Direct Reference to Biometric Data

Upon reviewing the CBAs for five professional sports leagues in North
America, only two make a direct reference to biometric data. The five CBAs
included are for the National Football League (NFL), NBA, MLB, NHL, and the
CFL:
CBA
NFL – NFLPA26
NHL – NHLPA27
CFL – CFLPA28
NBA – NBPA29
MLB – MLBPA30

Years Effective Direct Reference to
Biometric Data
2011-2020
Not included
2012-2022
Not included
2014-2018
Not included
2017-2024
Included
2017-2021
Included

Only the most recently negotiated CBAs explicitly mention biometric data
and trackers, while those negotiated only a few years earlier are silent on the issue.
As will be discussed, while the NFL’s CBA does reference wearable sensors on
athletes, it does not contain any explicit reference to biometric data, nor does it
provide for any substantial regulations on the collection, use, or disclosure of the
data. This pattern demonstrates that the issue of tracking and recording biometric
data has only recently become a priority for professional athletes.

“Collective Bargaining Agreement”, 2011, online (pdf): NFL Communications
<https://nfllabor.files.wordpress.com/2010/01/collective-bargaining-agreement-2011-2020.pdf> [NFLNFLPA Agreement].
27 NHL-NHLPA Agreement, supra note 21.
28 “Collective Bargaining 2014-2018”, online (pdf): CFLPA <https://cflpa.com/download/collectivebargaining-agreement-2014-2018/> [CFL-CFLPA Agreement].
29 “2017 NBA-NBPA Collective Bargaining Agreement”, online (pdf): NBPA <https://nbpa.com/cba/>
[NBA-NBPA Agreement].
30 “2017-2021 Basic Agreement”, online (pdf): Major League Baseball Players
<http://www.mlbplayers.com/pdf9/5450407.pdf> [MLB-MLBPA Agreement].
26
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National Basketball Association
The current CBA between the NBA and the National Basketball Players
Association (NBPA) came into effect July 1, 2017, and contains a comprehensive
set of regulations for the use of biometric trackers by athletes.31 While these
regulations protect the athletes from many of the potential harms arising from
misuse of the biometric data, the CBA does not directly assign ownership rights
to the biometric data collected. Even though the question of ownership is left
unanswered, a review of the rights and regulations negotiated for in the CBA is
instructive in demonstrating the athletes’ concerns regarding biometric data.
These regulations are in section 13 of Article XXII “Player Health &
Wellness,” and give a broad definition to “wearables”, defining them as a device
that measures movement, biometric, health, fitness and performance
information.32 The first part of this section creates a Joint Advisory Committee
on “wearables” with three members each from the NBA and NBPA, none of
who are allowed to have any interest in a “wearables” company. This Joint
Advisory Committee has two functions: to review requests for approval of
wearable devices submitted by teams, the NBA, or NBPA, and to set cyber
security standards for the storage of data collected.33 The requests are evaluated
for accuracy and potential harm to athletes, and teams cannot request athletes to
use any device until it has received approval.34 Devices that were already in use
before the agreement are temporarily grandfathered in, until the Joint Advisory
Committee is able to review the devices and the data security standards in place.35
The section then goes on to set out standards and restrictions on the use of
biometric tracking devices by teams. While teams may request an athlete to use
an approved device, such use is voluntary, and a team’s request must be
accompanied by a written explanation of “(i) what the device will measure, (ii)
what each such measurement means; and (iii) the benefits to the athlete in
obtaining such data.”36 Therefore, NBA athletes will be fully informed of the data

NBA-NBPA Agreement, supra note 29 at art XXII s 13, art XXXIX s 1.
Ibid at art XXII s 13(a).
33 Ibid at art XXII s 13(c).
34 Ibid at art XXII ss 13(c), 13(e).
35 Ibid at art XXII s 13(f).
36 Ibid at art XXII s 13(g).
31
32

12

MONEYBALL IN THE ERA OF BIOMETRICS

Vol. 28

collected about them before they agree to their use, directly addressing the root
issue of many potential inequitable outcomes between the team and the athletes.
This CBA also contemplates some of the potential harms from the misuse
of this data identified earlier. Athletes are given full access to all of their data, and
the data cannot be used to influence contract or trade negotiations, with teams
liable for fines up to $250,000 for violations.37 These provisions, while potentially
hard to enforce, directly address the potential for teams to engage in bad-faith
bargaining. The CBA also prohibits the data from being made public or used for
any commercial purpose.38 This prohibition recognizes the commercial nature of
this information, as it protects athletes by preventing the team or the NBA from
capitalizing on athlete data and instead compels the parties to continue to
negotiate for the commercialization of said data.39 Overall, the CBA between the
NBA and NBPA provides a comprehensive regulatory regime for the
implementation of biometric tracking devices that protects the economic, privacy,
and safety interests of the athletes.

Major League Baseball
The current CBA between the MLB and the Major League Baseball Players
Association (MLBPA) came into effect December 1, 2016, and runs until
December 1, 2021.40 Similar to the NBA’s CBA, the agreement contains a section
detailing the “approval, use and implementation of wearable technology” that
collects biometric data, and sets out regulations designed to safeguard the athletes
from the teams’ misuse of this data.41 Another similarity the agreement shares
with the NBA’s CBA is that it too does not directly assign the ownership rights
to the biometric data collected. A review of the MLB’s CBA illustrates the
concerns the MLBPA had while negotiating the agreement, and how these
concerns contrast to those negotiated for by the NBPA.
In the agreement, wearable technology is given a broad definition, referring
to “any equipment, program, software, device or attire which is designed to
Ibid at art XXII s 13(h).
Ibid at art XXII s 13(i).
39 Ibid.
40 MLB-MLBPA Agreement, supra note 30 at art XXVI.
41 MLB-MLBPA Agreement, supra note 30 at Attachment 56.
37
38
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collect and/or analyze information or data related to [an athlete’s] health or
performance at any location (including on-field, off-field and/or away from the
ballpark).”42 Not only does this definition capture the devices contemplated by
this paper, but it also includes devices that would be assigned by teams to take
measurements of the athletes off the field. The inclusion of this broad definition
is a proactive move by the MLBPA, as the issue of off-field measurements is very
likely to be contentious. Already, in 2015, the NFLPA filed a grievance against
the NFL for teams mandating the use of sleep monitoring devices on their
athletes without the approval of the NFLPA.43
The agreement between the MLB and MLBPA follows a similar structure
to the NBA’s CBA in regard to regulating biometric tracking devices. The existing
Playing Rules Committee must approve all wearable technology before an athlete
can use it.44 To assist in the approval process, the agreement creates a Joint
Committee on Wearable Technology, with members from both the MLB and the
MLBPA, to review applications for new wearable technologies and to provide the
Playing Rules Committee with recommendations.45 Unlike the NBA’s CBA,
however, the agreement does not contain guidelines or standards for the
Committee to base its decision on.
The agreement gives the athletes a great deal of agency regarding the use
and implementation of biometric tracking devices and demonstrates a great
concern for the privacy rights of the athletes. The use of these devices is strictly
voluntary, and teams must provide athletes with a written explanation of the
technology being proposed, as well as a list of every person who will have access
to the data collected.46 The agreement limits this list to eight identified positions
within team management, and gives the athlete the ability to restrict or expand
this list.47 The biometric data collected is to be treated as highly confidential, even
after the expiration of the agreement.48 It does not become part of the athlete’s
Ibid at Attachment 56, s1.
Tom Pelissero, “NFLPA files grievance over sleep monitoring devices being used by teams”, USA Today
(22 October 2015), online: <https://www.usatoday.com/story/sports/nfl/2015/10/22/nflpa-nfl-sleepmonitors/74402474/>.
44MLB-MLBPA Agreement, supra note 30 at Attachment 56, s 6.
45 Ibid at s 7.
46 Ibid at ss 2, 3.
47 Ibid at s 4.
48 Ibid.
42
43
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medical record, and therefore will not be available to a new team if he is traded.49
Further, the athlete has the ability to request a copy of all of the data the team has
collected, as well as to request that the team delete the data at any point.50
While the agreement demonstrates a strong concern for the athlete’s
privacy, when compared to the NBA’s CBA it contains relatively little protection
on how the data will be used by teams, thus doing less to prevent many of the
inequitable outcomes contemplated earlier. The only explicit limitation on teams
and the league is that any commercial use or exploitation of the data is
prohibited.51 While this potentially leaves open the opportunity for athletes
themselves to benefit commercially from the data, it likely does not provide
athletes with protections from the potential inequitable outcomes in contract and
trades negotiations identified earlier.

National Football League
The current CBA between the NFL and the National Football League Players
Association (NFLPA) came into effect in 2011, making it the oldest CBA to reference
wearable technology and sensors.52 Unlike the NBA and MLB agreements, however, it
is clear upon reviewing the NFL’s CBA that the section was not intended to provide
comprehensive regulation over the use of wearable biometric trackers, instead leaving
those details to be negotiated by the parties later. Given the sparse detail in the section,
it is unsurprising that the agreement also does not assign the ownership rights to the
data collected.

The sub-section dealing with sensors, tucked away under the section “OnField Microphones and Sensors”, itself under the article titled “Miscellaneous,”
applies to “sensors or other non-obtrusive tracking devices,” and divides these
into two categories based on their purpose.53 Those that are used for health and
medical purposes of athletes can only be implemented after the NFL receives the
NFLPA’s consent.54 While the agreement gives no criteria by which the NFLPA
will evaluate proposals, the NFLPA did release a form titled “Sensor Technology
Ibid.
Ibid at ss 3, 4.
51 Ibid at s 5.
52 NFL-NFLPA Agreement, supra note 26 at xiv.
53 Ibid at art 51, s 13.
54 Ibid.
49
50
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CBA Compliance Form” in the 2015 preseason.55 While this form is private, it
can be presumed to include some requirements by which the NFLPA would
evaluate proposals by teams. The agreement also contemplates sensors
implemented to collect information about the athlete’s performance and
movement during NFL games. The agreement gives the NFL the ability to require
athletes to wear these sensors, except for those placed on the athletes’ helmets,
which still require the consent of the NFLPA.56
While the agreement lists a set of procedures intended to protect athletes
from the misuse of in-game audio recordings captured under the section, it is
silent on the teams’ and the league’s intended use of the personal health data
collected by these wearable sensors.57 Thus, while the NFLPA may be able to
negotiate regulations separately, as it stands the CBA does little to protect the
athletes from the potential harms identified earlier.
Reading-in Ownership Rights

The current CBA between the NFL and the National Football League
Players Association (NFLPA) came into effect in 2011, making it the oldest CBA
to reference wearable technology and sensors.58 Unlike the NBA and MLB
agreements, however, it is clear upon reviewing the NFL’s CBA that the section
was not intended to provide comprehensive regulation over the use of wearable
biometric trackers, instead leaving those details to be negotiated by the parties
later. Given the sparse detail in the section, it is unsurprising that the agreement
also does not assign the ownership rights to the data collected.
The sub-section dealing with sensors, tucked away under the section “OnField Microphones and Sensors”, itself under the article titled “Miscellaneous,”
applies to “sensors or other non-obtrusive tracking devices,” and divides these
into two categories based on their purpose.59 Those that are used for health and
medical purposes of athletes can only be implemented after the NFL receives the
Pelissero, supra note 43.
NFL-NFLPA Agreement, supra note 26 at art 51, s 13(c).
57 Ibid.
58 NFL-NFLPA Agreement, supra note 26 at xiv.
59 Ibid at art 51, s 13.
55
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NFLPA’s consent.60 While the agreement gives no criteria by which the NFLPA
will evaluate proposals, the NFLPA did release a form titled “Sensor Technology
CBA Compliance Form” in the 2015 preseason.61 While this form is private, it
can be presumed to include some requirements by which the NFLPA would
evaluate proposals by teams. The agreement also contemplates sensors
implemented to collect information about the athlete’s performance and
movement during NFL games. The agreement gives the NFL the ability to require
athletes to wear these sensors, except for those placed on the athletes’ helmets,
which still require the consent of the NFLPA.62
While the agreement lists a set of procedures intended to protect athletes
from the misuse of in-game audio recordings captured under the section, it is
silent on the teams’ and the league’s intended use of the personal health data
collected by these wearable sensors.63 Thus, while the NFLPA may be able to
negotiate regulations separately, as it stands the CBA does little to protect the
athletes from the potential harms identified earlier.

LEGISLATION
Since the question of biometric data ownership is not answered, either
directly or indirectly, by the CBAs, the next consideration is whether applicable
legislation dictates the assignment of ownership rights. As mentioned, this
analysis is from the perspective of a professional athlete who plays in, and is a
resident of, Ontario. Thus, both Ontario and federal legislation is potentially
applicable to this athlete and must be reviewed. The two pieces of legislation that
are potentially applicable and will be analyzed are the Personal Health Information
Protection Act and the Personal Information Protection and Electronic Documents Act.64

Ibid.
Pelissero, supra note 43.
62 NFL-NFLPA Agreement, supra note 26 at art 51, s 13(c).
63 Ibid.
64 SO 2004, c3 [PHIPA]; SC 2000, c5 [PIPEDA].
60
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The Personal Health Information Protection Act

The Personal Health Information Protection Act (PHIPA) was passed by the
Ontario Legislature in 2004 in recognition of the sensitive nature of health
information, and in an effort to balance the privacy interests of individuals with
the operational needs of those in the healthcare system.65 Similar to the CBAs
explored earlier, PHIPA sets out rules for the collection, use, and disclosure of
personal health information by health care practitioners, and gives individuals a
right to access their own personal health information.66 PHIPA also obligates
those who hold the personal health information to correct any inaccuracies that
are brought to their attention.67 Before examining these obligations further, first
we must determine whether PHIPA is applicable to a private sports organization
based in Ontario that mandates athletes to wear biometric trackers.

Applicability of PHIPA
The obligations of PHIPA apply when a health information custodian
collects personal health information. Exploring the definitions of these terms
reveals that it is likely PHIPA would apply to a private professional sports
organization, given certain assumptions.
The collection of biometric data through wearable devices by professional
sports teams easily meets the definitions given in PHIPA for the terms “personal
health information” and to “collect.” PHIPA defines personal health information
as “identifying information about an individual in oral or recorded form, if the
information relates to the physical or mental health of the individual.” 68 The
biometric data of athletes would easily be captured by this definition. This data is
a detailed analysis of the athlete’s physical health, and by its very nature would be
identifying information about the specific athlete. PHIPA further defines
collection, “in relation to personal health information, [as meaning] to gather,
acquire, receive or obtain the information by any means from any source.”69
Ontario, Information and Privacy Commissioner, “A Guide to the Personal Health Information Protection Act”,
(Toronto: IPC, December 2004), online (pdf): <https://www.ipc.on.ca/wpcontent/uploads/Resources/hguide-e.pdf>.
66 Personal Health Information Protection Act, SO 2004, c3, s 1(a)(b).
67 Ibid at s 1(c).
68 Ibid at s 4(1)(a).
69 Ibid at s 2.
65

18

MONEYBALL IN THE ERA OF BIOMETRICS

Vol. 28

Given this broad definition, the purposeful use of sophisticated biometric
trackers would qualify under this definition as well.
Where the uncertainty as to applicability arises is whether the professional
sports team or the team physician is considered a health information custodian.
PHIPA defines a health information custodian as a “person or organization
described in one of the following paragraphs who has custody or control of
personal health information as a result of or in connection with performing the
person’s or organization’s powers or duties or the work described in the
paragraph,” and then goes on to list eight situations.70
The first situation is the most applicable, as it refers to “a health care
practitioner,”71 which is further defined to include “(a) a person who is a member
within the meaning of the Regulated Health Professions Act, 1991 and who provides
health care, … or (d) any other person whose primary function is to provide
health care for payment.”72 While this focus on individuals in the definition would
seem to exclude the private sports organization, given the biometric data’s
personal nature, and the stated purpose of the act to protect this information, a
purposive interpretation could capture the sports organization vicariously
through the actions of the team physician administering or interpreting the
biometric data collected.
Assuming that the team’s physician is not a member of a health profession
college, negating subsection (a) of the definition, there is still a strong argument
that the team would be captured under subsection (d), as collecting biometric data
would be considered providing health care. Health care is defined under PHIPA
as:
any observation, examination, assessment, care, service or
procedure that is done for a health-related purpose and that (a)
is carried out or provided to diagnose, treat or maintain an
individual’s physical or mental condition, (b) is carried out or
provided to prevent disease or injury or to promote health…73

Ibid at s 3(1).
Ibid at s 3(1)(a).
72 Ibid at s 2.
73 Ibid at s 2.
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As discussed earlier, part of the purpose of tracking biometric data is to
gather more information on how athletes are recovering from injuries and to
maintain their health, a purpose which would seemingly fit into the above
definition. Therefore, if the team physician is directly involved in the collection
and interpretation of biometric data, there is a strong argument that PHIPA
would apply. The organization’s physician provides health care for the team, and
part of the purpose of collecting the athlete’s biometric data is to improve their
health. Even if the team physician were not sufficiently involved in the
administration of the biometric tracking, the staff member responsible for its
administration would likely be seen as a health care practitioner. Given the above
purposive interpretation of health care, the staff member’s actions in
administering the biometric tracking devices would likely be captured under the
above definition, making the staff member a health care practitioner, and in turn
a health information custodian under PHIPA. Overall, there is a strong argument
that a professional sports team based in Ontario that collects the biometric data
of its athletes would be subject to the obligations of PHIPA.
Further, while conclusions as to conflicts of law are beyond the scope of
this paper, the broad definitions given to the terms “individual”, “health care”,
and “health care practitioner” raise the potential for PHIPA to apply to teams
based outside of Ontario while they are playing (and collecting biometric data)
inside of Ontario. While Provincial legislatures lack the legislative competence to
enact laws having extraterritorial effect, this competence clearly exists within the
boundaries of the province.74

Obligations Under PHIPA
Similar to the CBAs discussed earlier, if PHIPA applies, its application
results in various obligations on the team regarding the collection, storage, and
use of the biometric data.
To begin, the team has to receive the athlete’s consent before collecting their
biometric data.75 This consent must be knowledgeable. The athlete has to know
why the biometric data is being collected and used, and know that that they have
74
75

Peter Hogg, Constitutional law of Canada, 5th ed (Scarborough: Thomson Carswell, 2017) at s 13.3(a)-(b).
PHIPA, supra note 60 at s 29.
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the ability to withhold consent.76 Further, the athlete’s consent cannot be implied
since the biometric data is likely shared with multiple people within the
organization and the athlete must expressly consent to this data sharing.77
The team can only use the biometric data for the purposes that were
disclosed to the athlete when it was collected, and for functions reasonably
necessary to carry out the disclosed purpose.78 Further, the athlete has a legal right
of access to the data record. If, upon reviewing their record, an athlete believes
that the data is inaccurate or incomplete, they have a right to request that the team
correct the information.79 However, the authority still lies with the team to
determine if the record is indeed inaccurate or incomplete.80 If an athlete believes
that their team has acted contrary to the obligations under PHIPA, they can file
a complaint with the Information and Privacy Commissioner. 81 The Information
and Privacy Commissioner can then make an order compelling the team to take
the actions necessary to become compliant with PHIPA.82 Absent from the
legislation are provisions dictating or expanding upon the ownership of the data
collected.
If non-Ontario teams were found to be subject to PHIPA while playing in
Ontario, these teams would face the additional obligation to either obtain the
athlete’s consent, or establish that disclosure is reasonably necessary to the
provision of health care to the athlete, before the biometric data could be
disclosed outside of Ontario.83

Ibid at ss 18(1)(b), 18(5).
Ibid at ss 18(3)(a), 50(1)(a).
78 Ibid at ss 37(1)(a).
79 Ibid at s 55(1).
80 Ibid at s 55(9).
81 Ibid at s 56(1).
82 Ibid at s 61(1).
83 Ibid at s 50(1).
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Conclusions Regarding CBA Compliance with PHIPA
The obligations set out in PHIPA represent the minimum that must be done
by those who fall within the definition of a health information custodian. In some
regards the CBAs in the NBA and MLB go above the standards set by PHIPA.
Both agreements require teams to provide athletes with written explanations of
the biometric data to be collected, and the purpose for which the team is
collecting it, provisions which would satisfy the requirement for express
knowledgeable consent contained in PHIPA. Both CBAs further give athletes
explicit rights of access to the biometric data, meeting this obligation in PHIPA
as well. While the CBAs are silent in regard to other obligations under PHIPA,
neither of the CBAs directly contradicts PHIPA.
For all leagues, whether or not they meet the definition of a health
information custodian, the obligations imposed by PHIPA should serve as an
indication of best practices for the management of biometric data. These
obligations address many of the potential harms associated with the collection of
biometric data identified earlier by giving the athlete knowledge of the
information collected and by respecting the privacy interests of the athlete. So,
while PHIPA does not assist us in determining who has ownership over biometric
data collected, the legislation is at least instructive in how the data should be
handled once collected.
Personal Information Protection and Electronic Documents Act

The Personal Information Protection and Electronic Documents Act (PIPEDA) is a
piece of federal legislation that governs the collection, use and disclosure of all
personal information, not just health information, by private entities.84 While
there is some uncertainty as to whether PHIPA applies to professional sports
teams, it is clear that PIPEDA is applicable to Ontario based professional sports
teams.

84

PIPEDA, supra note 60 at s 3.
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Applicability of PIPEDA
PIPEDA applies to organizations that collect, use, or disclose personal
information in the course of commercial activities, and the biometric data
collected from athletes by teams would easily fall into these defined terms.85 To
begin, the biometric data of athletes would likely be captured under the definition
of personal information because it is linked to an individual.86 As the Supreme
Court of Canada has held, the definition of personal information must be given
a broad and expansive interpretation.87
Second, a plain reading of the statute supports the collection of the
biometric data as falling under the definition of a commercial activity. PIPEDA
defines commercial activity to refer to, “any particular transaction, act or conduct
or any regular course of conduct that is of a commercial character…” 88 As the
acquisition of talented athletes, and their continued and improved health and
fitness, is essential to the commercial success of the team, it is very likely that the
collection of athletes’ biometric data by their teams would be considered in the
course of a commercial activity.
This interpretation is further supported by the case law on this section. In
Rousseau v. Wyndowe89 the Federal Court of Appeal evaluated whether an
independent medical examination undertaken to obtain disability benefits was of
a commercial nature. To do so, the court broke down the relationships involved.
The relationship between the doctor and the insurance company, who is paying
for the independent medical examination, was of a commercial nature, and the
relationship between the insured and the insurance company was clearly of a
commercial nature. In the context of these two commercial relationships, the
court found that the introduction of the third relationship, between the insured
and the doctor, did not defeat the commercial nature of the overall transaction.
This analysis can be directly applied to the situation of professional athletes who
have their biometric data tracked. The relationship between the athlete and the
Ibid at s 4(1)(a).
Ibid at s 2(1).
87 See Canada (Information Commissioner) v Canada (Commissioner of the Royal Canadian Mounted
Police), 2003 SCC 8, [2003] 1 SCR 66, at para 23.
88 PIPEDA, supra note 60 at s 2(1).
89 2008 FCA 39.
85
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team is clearly commercial in nature, as is the relationship between the physician
and/or technicians collecting the biometric data. As the court explained in
Rousseau¸ the physician and/or technician is merely the agent of the team, and the
collection of the biometric data would be an element of the commercial
relationship between the team and its athletes.90
It should be noted, however, that PHIPA and PIPEDA are effectively
mutually exclusive in their application. If a team is found to be a health
information custodian under PHIPA, then the obligations under PIPEDA are
prescribed not to apply.91
Again, while conclusions as to conflicts of law are beyond the scope of this
paper, there is precedent for the obligations of PIPEDA to apply to nonCanadian teams while they are playing (and collecting biometric data) inside of
Ontario if there exists a “real and substantial connection” between the parties
and/or the facts giving rise to the complaint in Canada.92

Obligations Under PIPEDA
As with PHIPA, PIPEDA is very instructive in setting out standards for the
collection, use, and disclosure of the biometric information collected, and
addresses many of the potential harms identified earlier. However, PIPEDA also
shares PHIPA’s issue; it does not provide any guidance as to the ownership rights
over the personal information data collected. Instead it only dictates how the
personal information can be collected and used. Regardless, a brief review of the
obligations imposed demonstrates the further regulations with which a
professional sports team must comply while collecting its athletes’ biometric data.
PIPEDA would obligate professional sports teams to collect the biometric
data of athletes in accordance with the obligations set out in Schedule 1 of the
act.93 These obligations echo many of the requirements found in PHIPA and
negotiated into CBAs. For the team to comply with Schedule 1 of PIPEDA, they
must get the athlete’s consent before collecting their data. 94 The team must
Ibid at paras. 35-36.
Health Information Custodians in the Province of Ontario Exemption Order, SOR 2005, Reg 399, s 1.
92 See T (A) v Globe24h.com, 2017 FC 114; Lawson v Accusearch Inc, 2007 FC 125.
93 PIPEDA, supra note 60 at s 5(1).
94 Ibid at Schedule 1, 4.3.
90
91
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disclose to the athlete how the data will be used before it is collected, can only
collect data that is necessary for this purpose, and can only use the data for this
stated purpose.95 If the team wants to use the data for a new purpose, they must
get the athlete’s consent beforehand.96 The athlete has a right to access their
biometric data, and can challenge inaccurate or incomplete data. 97 Similar to the
MLB’s CBA, the team also has the obligation to ensure that the biometric data
collected is stored securely.98 Further, the team must identify an individual
responsible for compliance with these obligations, and to whom the athletes
would bring forward any concerns with compliance.99
Unlike privacy laws established by the European Union that prohibit the
transfer of personal information to another jurisdiction without adequate
protection, PIPEDA places the obligation for compliance with the organization.
Thus, if PIPEDA is found to apply to the biometric data collected by a nonCanadian team playing inside of Ontario, the team would not need to
demonstrate that the privacy protections in the United States of America were
adequate. Rather, the team would be held directly accountable for the protection
of the personal information.100

ANALGOUS CASE LAW
The CBAs and the legislation all give detailed regulations for the collection,
use, and disclosure of biometric data, yet were all silent on the question of
ownership. As such, case law should be considered to determine whether the
athlete or the team owns the biometric data. While this question has not been
directly tested in court, we can look to the analogous situation of patient medical
records for an answer.

Ibid at Schedule 1, 4.2; Schedule 1, 4.4; Schedule 1, 4.5.
Ibid at Schedule 1, 4.2.4.
97 Ibid at Schedule 1, 4.9; Schedule 1, 4.9.5.
98 Ibid at Schedule 1, 4.7.1.
99 Ibid at Schedule 1, 4.10.
100 Office of the Privacy Commissioner of Canada, “Guidelines for Processing Personal Data Across
Borders” (January 2009) online: <https://www.priv.gc.ca/en/privacy-topics/personal-informationtransferred-across-borders/gl_dab_090127/>.
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Ownership of patient medical records presents a strong analogy to the
ownership of biometric data due to the nature of the information in question. In
both situations, the information is of a fundamentally intimate and personal
nature to the data’s source, yet the individual is unable to collect the information
without utilizing the skill and knowledge of others. This similarity can be
demonstrated through the comparison of a physician who runs a test, interprets
the results, and writes down her medical opinion into the patient’s medical record
to the team manager who measures an athlete’s biometric performance during a
practice, and uses the software and their knowledge to evaluate the athlete. The
functions of both a physician and team manager in these examples are
fundamentally similar, and often times would be taking the same measurements.
Therefore, evaluating discussions over the ownership of patient’s medical records
will provide informative and influential insight into the questions of ownership
over the biometric data of professional athletes.
The Supreme Court of Canada tackled this exact question in the 1992 case
of McInerney v MacDonald.101 Various physicians had treated the patient, Mrs.
MacDonald, and her medical record contained notes and reports from each of
these physicians over the years. When Mrs. MacDonald began seeing Dr.
McInerney, Dr. McInerney advised Mrs. MacDonald to stop the medication that
had been prescribed by previous physicians. Naturally, the nature of this advice
made Mrs. MacDonald begin to question the competency of her previous
physicians. As a result, Mrs. MacDonald wrote to Dr. McInerney to request a
copy of her complete medical record. Dr. McInerney replied by sending only
copies of the information she had prepared herself but refused to send copies of
any material prepared by other physicians. She claimed that work was the property
of the other respective doctors and that Mrs. MacDonald would have to contact
the other physicians individually to gain access to these records.102 In turn, Mrs.
MacDonald then made an application to the New Brunswick Court of Queen’s
Bench for an order directing the disclosure of her full medical record.103
Reflecting the difficult nature of answering this question, each level of court relied
[1992] 2 SCR 138, [1992] SCJ No 57 [McInerney SC].
Ibid, at para 2.
103 Ibid, at para 3.
101
102
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on different legal principles in coming to their answer regarding the questions of
ownership and access.
At the trial level, the court looked to the relationship between solicitor and
client, opining that “[ownership] of documents prepared by a lawyer on behalf of
a client rests with the client in a solicitor-client relationship and with the patient
in a physician-patient relationship.”104 While the Justices at the Court of Appeal
split on their decision, they were united in their rejection of the trial court’s
reasoning. The majority found that the case did not raise an issue over ownership
over the medical records, but rather over the right to access the records, and thus
did not dedicate much analysis to the discussion of ownership.105 The dissenting
Justice took the time to address the trial level decision further, stating “[even] in
a solicitor-client relationship, a client does not enjoy a right to the notes made by
a solicitor for the benefit of the solicitor in rendering the services for a client. The
Court has ruled in several decisions that the solicitor is the owner of them and
need not transmit them to the client,” distinguishing between documents
prepared for the benefit of the client and those prepared by the solicitor to assist
in the creation of client documents.106 When applied to the analogy of biometric
data collected from athletes, this distinction raises many questions about the
nature of the biometric data. Would the athlete own the raw data, and the team
own the report created after the data is analyzed by software? Is the client in this
analogy actually the team, with the solicitor being the company who designed the
biometric trackers and software? Unfortunately, the Supreme Court of Canada
did not incorporate this line of reasoning, rendering this distinction of little
assistance to my question.
Instead, the Supreme Court of Canada identified two issues on the appeal:
who held the property rights to patient medical records, and whether a patient
has a right to access their entire medical record if they do not hold the property
rights to it.107 The Court wasted little ink on the first issue, deferring to the policy
statement of the Canadian Medical Association and concluding “the physician,

McInerney v MacDonald, [1990] AN-B No 106, at para 6, [1990] NBJ No 106 (CA).
Ibid at para 27.
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institution or clinic compiling the medical records owns the physical record.”108
Therefore, to complete the analogy, if the institution compiling the medical
record of a patient owns the physical record, then the institution compiling the
biometric data of an athlete would own the biometric data. While this analogy
would also give the athlete a strong right to access the biometric data, the analogy
is unnecessary for this purpose as the right to access is already strongly entrenched
in both collective agreements and legislation.

CONCLUSION
After reviewing the CBAs negotiated between the players unions and the
various leagues and the applicable provincial and federal legislation, the most
definitive answer to the question of ownership over an athlete’s biometric data is
provided by the analogous case law governing the ownership of patient medical
records. The party that compiles the information owns the information. Since the
team owns the biometric trackers and compiles the information, the team
ultimately owns the data. This conclusion raises certain ethical questions. The
encroachment of these biometric tracking technologies allows for more of the
professional athlete’s body to be considered the property of the team, an issue
that will only grow the more invasive these biometric trackers become and the
more their use off the field is normalized.109 As we have discovered, however,
athletes are aware of the potential for the collection of biometric data to result in
either inequitable outcomes, or the loss of privacy interests, and they have made
their concerns known in the most recently negotiated CBAs. As discussed earlier,
provisions in the CBAs for the NBA and MLB explicitly prevent the biometric
data from being used to influence contract negotiations, from either party
monetizing the data, and put in place procedures for the approval and use of the
monitoring devices. With CBA renegotiations quickly approaching for the other
leagues, the rights and regulations found in the CBAs for the NBA and MLB will
almost certainly influence these future negotiations. As this paper has
demonstrated, representatives from these unions should make the regulation and
108
109
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protection of athletes’ biometric data a priority. The failure to do so could have
significant detrimental impacts on professional athletes.

